Autophagy regulation by microRNAs in chemotherapy resistance (Review)

Tianqiao Huang1, Zhen Xu1, Lin Cao2

  • 1Department of Otolaryngology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong 266000, P.R. China.

Oncology Reports
|June 26, 2020
PubMed

Insights

MicroRNAs (miRNAs) are key regulators of autophagy, a process that impacts chemotherapy resistance in tumors. Targeting miRNAs involved in autophagy may overcome drug resistance and improve cancer treatment efficacy.

Area of Science:

  • Oncology
  • Molecular Biology

Background:

  • Chemotherapy is a cornerstone of cancer treatment, but drug resistance significantly limits its effectiveness.
  • Autophagy, a cellular degradation process, plays a crucial role in the development of chemoresistance.
  • MicroRNAs (miRNAs) are emerging as critical regulators of autophagy and chemoresistance.

Purpose of the Study:

  • To explore the role of microRNAs (miRNAs) in regulating autophagy-mediated chemoresistance.
  • To investigate the potential of targeting miRNA-autophagy pathways for overcoming drug resistance in cancer therapy.

Main Methods:

  • Literature review of recent advancements in chemotherapy, autophagy, and miRNA research.
  • Analysis of molecular mechanisms linking miRNAs, autophagy, and drug resistance.
  • Identification of key molecules and pathways involved in miRNA-regulated autophagy.

Main Results:

  • A significant number of molecules targeted by miRNAs are involved in the autophagic pathway.
  • miRNAs regulating autophagy influence the therapeutic efficacy of chemotherapy drugs.
  • miRNA-mediated autophagy modulation presents a promising strategy to overcome chemoresistance.

Conclusions:

  • MicroRNAs are critical regulators of autophagy and play a significant role in chemoresistance.
  • Targeting specific miRNAs involved in autophagy holds potential for enhancing chemotherapy effectiveness.
  • Further research into miRNA-autophagy interactions is warranted for clinical applications in overcoming drug resistance.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.5K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.6K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.5K
Autophagy01:27

Autophagy

Autophagy is a self-digesting process by which a cell protects itself from threats both within and outside the cell, ranging from abnormal proteins to invading bacteria. In this process, obsolete components of the cell and invading microbes are degraded by hydrolytic enzymes active in an acidic environment of the lysosomal lumen.
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
5.5K
Destabilization of Microtubules01:45

Destabilization of Microtubules

The destabilization of microtubules can occur during different stages of the microtubule lifecycle, such as nucleation or elongation. It can take place at either end of the microtubule or in the microtubule lattices as a whole. The lifespan of individual microtubules within a cell varies according to the cell type and stage of the cell cycle. During interphase, the lifespan of the microtubule is about 30 minutes, while during cell division, it is about 15 minutes. In axonal microtubules of...
3.4K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K